Selected research
Industry Research
Automated Biobanking Solution Industry Research Report 2026
Market perspective
The global Automated Biobanking Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Automated Biobanking Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Automated Biobanking Solution market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Automated Biobanking Solution market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Automated Biobanking Solution include Thermo Fisher Scientific, Air Liquide, Brooks Automation, SPT Labtech, Modul-Bio, Azenta, LabVantage, OMNI Life Science and Calibre Scientific, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Automated Biobanking Solution market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Automated Biobanking Solution.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Automated Biobanking Solution Market by Company
Thermo Fisher Scientific
Air Liquide
Brooks Automation
SPT Labtech
Modul-Bio
Azenta
LabVantage
OMNI Life Science
Calibre Scientific
IQVIA
XiltriX
Esco Lifesciences Group
Hangzhou Baocheng Biotechnology
Shanghai Origincell Biological Cryo Equipment
Anhui Zhongke Meiling Cryogenics
Shanghai H-VISIONS Technology
Qingdao Haier Biomedical
Qingdao AUCMA Biomedical
Qingdao Dashoo
Qingdao Hisense Medical
Automated Biobanking Solution Segment by Type
Sample Preparation Devices
Cryobiology Storage System
Cryobiology Storage Consumables
Environmental Monitoring System
Laboratory Information Management Systems (LIMS)
Automated Biobanking Solution Segment by Application
Universities
Hospitals
Clinical Research Laboratories
Others
Automated Biobanking Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automated Biobanking Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Automated Biobanking Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automated Biobanking Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Automated Biobanking Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sample Preparation Devices
- Cryobiology Storage System
- Cryobiology Storage Consumables
- Environmental Monitoring System
- Laboratory Information Management Systems (LIMS)
Applications
- Universities
- Hospitals
- Clinical Research Laboratories
- Others
Companies covered
- Thermo Fisher Scientific
- Air Liquide
- Brooks Automation
- SPT Labtech
- Modul-Bio
- Azenta
- LabVantage
- OMNI Life Science
- Calibre Scientific
- IQVIA
- XiltriX
- Esco Lifesciences Group
- Hangzhou Baocheng Biotechnology
- Shanghai Origincell Biological Cryo Equipment
- Anhui Zhongke Meiling Cryogenics
- Shanghai H-VISIONS Technology
- Qingdao Haier Biomedical
- Qingdao AUCMA Biomedical
- Qingdao Dashoo
- Qingdao Hisense Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Automated Biobanking Solution by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Sample Preparation Devices
- 2.2.3 Cryobiology Storage System
- 2.2.4 Cryobiology Storage Consumables
- 2.2.5 Environmental Monitoring System
- 2.2.6 Laboratory Information Management Systems (LIMS)
- 2.3 Automated Biobanking Solution by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Universities
- 2.3.3 Hospitals
- 2.3.4 Clinical Research Laboratories
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Automated Biobanking Solution Breakdown Data by Type
- 3.1 Global Automated Biobanking Solution Historic Market Size by Type (2021-2026)
- 3.2 Global Automated Biobanking Solution Forecasted Market Size by Type (2027-2032)
4 Automated Biobanking Solution Breakdown Data by Application
- 4.1 Global Automated Biobanking Solution Historic Market Size by Application (2021-2026)
- 4.2 Global Automated Biobanking Solution Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Automated Biobanking Solution Market Perspective (2021-2032)
- 5.2 Global Automated Biobanking Solution Growth Trends by Region
- 5.2.1 Global Automated Biobanking Solution Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Automated Biobanking Solution Historic Market Size by Region (2021-2026)
- 5.2.3 Automated Biobanking Solution Forecasted Market Size by Region (2027-2032)
- 5.3 Automated Biobanking Solution Market Dynamics
- 5.3.1 Automated Biobanking Solution Industry Trends
- 5.3.2 Automated Biobanking Solution Market Drivers
- 5.3.3 Automated Biobanking Solution Market Challenges
- 5.3.4 Automated Biobanking Solution Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Automated Biobanking Solution Players by Revenue
- 6.1.1 Global Top Automated Biobanking Solution Players by Revenue (2021-2026)
- 6.1.2 Global Automated Biobanking Solution Revenue Market Share by Players (2021-2026)
- 6.2 Global Automated Biobanking Solution Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Automated Biobanking Solution Head Office and Area Served
- 6.4 Global Automated Biobanking Solution Players, Product Type & Application
- 6.5 Global Automated Biobanking Solution Manufacturers Established Date
- 6.6 Global Automated Biobanking Solution Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Automated Biobanking Solution Market Size (2021-2032)
- 7.2 North America Automated Biobanking Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Automated Biobanking Solution Market Size by Country (2021-2026)
- 7.4 North America Automated Biobanking Solution Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Automated Biobanking Solution Market Size (2021-2032)
- 8.2 Europe Automated Biobanking Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Automated Biobanking Solution Market Size by Country (2021-2026)
- 8.4 Europe Automated Biobanking Solution Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Automated Biobanking Solution Market Size (2021-2032)
- 9.2 Asia-Pacific Automated Biobanking Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Automated Biobanking Solution Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Automated Biobanking Solution Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Automated Biobanking Solution Market Size (2021-2032)
- 10.2 South America Automated Biobanking Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Automated Biobanking Solution Market Size by Country (2021-2026)
- 10.4 South America Automated Biobanking Solution Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Automated Biobanking Solution Market Size (2021-2032)
- 11.2 Middle East & Africa Automated Biobanking Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Automated Biobanking Solution Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Automated Biobanking Solution Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Automated Biobanking Solution Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 Air Liquide
- 12.2.1 Air Liquide Company Information
- 12.2.2 Air Liquide Business Overview
- 12.2.3 Air Liquide Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.2.4 Air Liquide Automated Biobanking Solution Product Portfolio
- 12.2.5 Air Liquide Recent Developments
- 12.3 Brooks Automation
- 12.3.1 Brooks Automation Company Information
- 12.3.2 Brooks Automation Business Overview
- 12.3.3 Brooks Automation Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.3.4 Brooks Automation Automated Biobanking Solution Product Portfolio
- 12.3.5 Brooks Automation Recent Developments
- 12.4 SPT Labtech
- 12.4.1 SPT Labtech Company Information
- 12.4.2 SPT Labtech Business Overview
- 12.4.3 SPT Labtech Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.4.4 SPT Labtech Automated Biobanking Solution Product Portfolio
- 12.4.5 SPT Labtech Recent Developments
- 12.5 Modul-Bio
- 12.5.1 Modul-Bio Company Information
- 12.5.2 Modul-Bio Business Overview
- 12.5.3 Modul-Bio Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.5.4 Modul-Bio Automated Biobanking Solution Product Portfolio
- 12.5.5 Modul-Bio Recent Developments
- 12.6 Azenta
- 12.6.1 Azenta Company Information
- 12.6.2 Azenta Business Overview
- 12.6.3 Azenta Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.6.4 Azenta Automated Biobanking Solution Product Portfolio
- 12.6.5 Azenta Recent Developments
- 12.7 LabVantage
- 12.7.1 LabVantage Company Information
- 12.7.2 LabVantage Business Overview
- 12.7.3 LabVantage Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.7.4 LabVantage Automated Biobanking Solution Product Portfolio
- 12.7.5 LabVantage Recent Developments
- 12.8 OMNI Life Science
- 12.8.1 OMNI Life Science Company Information
- 12.8.2 OMNI Life Science Business Overview
- 12.8.3 OMNI Life Science Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.8.4 OMNI Life Science Automated Biobanking Solution Product Portfolio
- 12.8.5 OMNI Life Science Recent Developments
- 12.9 Calibre Scientific
- 12.9.1 Calibre Scientific Company Information
- 12.9.2 Calibre Scientific Business Overview
- 12.9.3 Calibre Scientific Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.9.4 Calibre Scientific Automated Biobanking Solution Product Portfolio
- 12.9.5 Calibre Scientific Recent Developments
- 12.10 IQVIA
- 12.10.1 IQVIA Company Information
- 12.10.2 IQVIA Business Overview
- 12.10.3 IQVIA Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.10.4 IQVIA Automated Biobanking Solution Product Portfolio
- 12.10.5 IQVIA Recent Developments
- 12.11 XiltriX
- 12.11.1 XiltriX Company Information
- 12.11.2 XiltriX Business Overview
- 12.11.3 XiltriX Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.11.4 XiltriX Automated Biobanking Solution Product Portfolio
- 12.11.5 XiltriX Recent Developments
- 12.12 Esco Lifesciences Group
- 12.12.1 Esco Lifesciences Group Company Information
- 12.12.2 Esco Lifesciences Group Business Overview
- 12.12.3 Esco Lifesciences Group Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.12.4 Esco Lifesciences Group Automated Biobanking Solution Product Portfolio
- 12.12.5 Esco Lifesciences Group Recent Developments
- 12.13 Hangzhou Baocheng Biotechnology
- 12.13.1 Hangzhou Baocheng Biotechnology Company Information
- 12.13.2 Hangzhou Baocheng Biotechnology Business Overview
- 12.13.3 Hangzhou Baocheng Biotechnology Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.13.4 Hangzhou Baocheng Biotechnology Automated Biobanking Solution Product Portfolio
- 12.13.5 Hangzhou Baocheng Biotechnology Recent Developments
- 12.14 Shanghai Origincell Biological Cryo Equipment
- 12.14.1 Shanghai Origincell Biological Cryo Equipment Company Information
- 12.14.2 Shanghai Origincell Biological Cryo Equipment Business Overview
- 12.14.3 Shanghai Origincell Biological Cryo Equipment Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.14.4 Shanghai Origincell Biological Cryo Equipment Automated Biobanking Solution Product Portfolio
- 12.14.5 Shanghai Origincell Biological Cryo Equipment Recent Developments
- 12.15 Anhui Zhongke Meiling Cryogenics
- 12.15.1 Anhui Zhongke Meiling Cryogenics Company Information
- 12.15.2 Anhui Zhongke Meiling Cryogenics Business Overview
- 12.15.3 Anhui Zhongke Meiling Cryogenics Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.15.4 Anhui Zhongke Meiling Cryogenics Automated Biobanking Solution Product Portfolio
- 12.15.5 Anhui Zhongke Meiling Cryogenics Recent Developments
- 12.16 Shanghai H-VISIONS Technology
- 12.16.1 Shanghai H-VISIONS Technology Company Information
- 12.16.2 Shanghai H-VISIONS Technology Business Overview
- 12.16.3 Shanghai H-VISIONS Technology Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.16.4 Shanghai H-VISIONS Technology Automated Biobanking Solution Product Portfolio
- 12.16.5 Shanghai H-VISIONS Technology Recent Developments
- 12.17 Qingdao Haier Biomedical
- 12.17.1 Qingdao Haier Biomedical Company Information
- 12.17.2 Qingdao Haier Biomedical Business Overview
- 12.17.3 Qingdao Haier Biomedical Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.17.4 Qingdao Haier Biomedical Automated Biobanking Solution Product Portfolio
- 12.17.5 Qingdao Haier Biomedical Recent Developments
- 12.18 Qingdao AUCMA Biomedical
- 12.18.1 Qingdao AUCMA Biomedical Company Information
- 12.18.2 Qingdao AUCMA Biomedical Business Overview
- 12.18.3 Qingdao AUCMA Biomedical Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.18.4 Qingdao AUCMA Biomedical Automated Biobanking Solution Product Portfolio
- 12.18.5 Qingdao AUCMA Biomedical Recent Developments
- 12.19 Qingdao Dashoo
- 12.19.1 Qingdao Dashoo Company Information
- 12.19.2 Qingdao Dashoo Business Overview
- 12.19.3 Qingdao Dashoo Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.19.4 Qingdao Dashoo Automated Biobanking Solution Product Portfolio
- 12.19.5 Qingdao Dashoo Recent Developments
- 12.20 Qingdao Hisense Medical
- 12.20.1 Qingdao Hisense Medical Company Information
- 12.20.2 Qingdao Hisense Medical Business Overview
- 12.20.3 Qingdao Hisense Medical Revenue in Automated Biobanking Solution Business (2021-2026)
- 12.20.4 Qingdao Hisense Medical Automated Biobanking Solution Product Portfolio
- 12.20.5 Qingdao Hisense Medical Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst